Review - Recent developments in nitric oxide donor drugs

被引:502
作者
Miller, M. R. [1 ]
Megson, I. L.
机构
[1] Univ Highlands and Islands, Free Rad Res Facil, Dept Diabet, Inverness IV2 3BL, Scotland
[2] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
关键词
nitric oxide; nitric oxide donor drugs; S-nitrosothiol; diazeniumdiolate; NONOate; furoxan; nitroaspirin; organic nitrate;
D O I
10.1038/sj.bjp.0707224
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the 1980s, the free radical, nitric oxide ( NO), was discovered to be a crucial signalling molecule, with wide- ranging functions in the cardiovascular, nervous and immune systems. Aside from providing a credible explanation for the actions of organic nitrates and sodium nitroprusside that have long been used in the treatment of angina and hypertensive crises respectively, the discovery generated great hopes for new NO- based treatments for a wide variety of ailments. Decades later, however, we are still awaiting novel licensed agents in this arena, despite an enormous research effort to this end. This review explores some of the most promising recent advances in NO donor drug development and addresses the challenges associated with NO as a therapeutic agent.British Journal of Pharmacology ( 2007).
引用
收藏
页码:305 / 321
页数:17
相关论文
共 227 条
[61]   ENDOTHELIAL FUNCTION IN HUMAN CORONARY-ARTERIES INVIVO - FOCUS ON HYPERCHOLESTEROLEMIA [J].
DREXLER, H ;
ZEIHER, AM .
HYPERTENSION, 1991, 18 (04) :90-99
[62]   Drug-eluting stents - The price is not right [J].
Eisenberg, Mark J. .
CIRCULATION, 2006, 114 (16) :1745-1754
[63]   0.4% Nitroglycerin ointment: In the treatment of chronic anal fissure pain [J].
Fenton C. ;
Wellington K. ;
Easthope S.E. .
Drugs, 2006, 66 (3) :343-349
[64]   IL-1β converting enzyme is a target for nitric oxide-releasing aspirin:: New insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs [J].
Fiorucci, S ;
Santucci, L ;
Cirino, G ;
Mencarelli, A ;
Familiari, L ;
Del Soldato, P ;
Morelli, A .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5245-5254
[65]   Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans [J].
Fiorucci, S ;
Mencarelli, A ;
Meneguzzi, A ;
Lechi, A ;
Renga, B ;
del Soldato, P ;
Morelli, A ;
Minuz, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (03) :635-641
[66]   NO-aspirin: mechanism of action and gastrointestinal safety [J].
Fiorucci, S ;
Del Soldato, P .
DIGESTIVE AND LIVER DISEASE, 2003, 35 :S9-S19
[67]   Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: A proof of concept endoscopic study [J].
Fiorucci, S ;
Santucci, L ;
Gresele, P ;
Faccino, RM ;
Del Soldato, P ;
Morelli, A .
GASTROENTEROLOGY, 2003, 124 (03) :600-607
[68]   Coxibs and cardiovascular disease [J].
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1709-1711
[69]   Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles [J].
Frost, MC ;
Meyerhoff, ME .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 72A (04) :409-419
[70]   Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contactincy medical devices [J].
Frost, MC ;
Reynolds, MM ;
Meyerhoff, ME .
BIOMATERIALS, 2005, 26 (14) :1685-1693